• SENSEX 77,250.10
    332.25 (+0.43%)
  • BANKNIFTY 55,540.05
    537.85 (+0.98%)
  • NSE
    1,824.90 1,878.00(%)
  • Bharti Airtel
    2,042.90 1,726.05(%)
  • Reliance Industries
    1,315.50 1,611.20(%)
  • SBI Life Insuran
    1,706.80 2,132.90(%)
  • Saregama India
    647.20 574.85(%)
  • Multi Comm. Exc.
    3,252.50 1,761.43(%)
  • Aster DM Quality
    710.25 890.95(%)
  • Shree Cement
    24,342.85 28,306.45(%)
  • Jio Platforms
    1,420.50 1,356.40(%)
  • SFC Enviro.
    397.60 354.05(%)
  • Global Health
    1,422.10 1,542.00(%)
  • HDFC Bank
    741.00 1,017.90(%)
  • BLS Polymers
    261.80 225.00(%)
  • J K Cements
    5,155.30 6,363.00(%)
  • Info Edg.(India)
    1,159.40 909.20(%)
  • ITC
    283.50 421.70(%)
  • SBI
    987.75 1,234.80(%)
  • M & M
    2,942.00 3,840.00(%)
  • TBO Tek
    1,522.00 1,005.50(%)
  • Fractal Analyt.
    839.45 1,119.60(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Ishita Drugs & Industries Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 3314.0
  • ISIN : INE806D01016
72.00 -1 (-1.77%)
  • As on 04 Nov 2026 (EOD)

  • Today’s Low

    72.00

  • Today’s High

    72.00

  • Open

    72.00

  • Perv Close

    73.30

  • 52W Low

    66.00

  • 52W High

    90.85

Key Indicators

  • P/E(TTM)

    30.51

  • Mar.Cap (₹Cr.)

    21.53

  • Div & Yield %

    0.00

  • Book Value(₹)

    38.69

  • Debt-Equity Ratio

    -1.77

  • AGM Date

    02-Nov-2026

  • EPS

    2.36

  • P/E Ratio

    30.51

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    21.53

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    2.99

  • BV (₹)

    38.70

  • Sales( ₹ in Cr.)

    14.66

  • NP (in Cr.)

    0.78

  • NP Var(%)

    -10.0

  • Div%

    0.0

  • CPS (₹)

    2.90

  • EPS (₹)

    2.60

  • Traded Value (₹ in Lakhs)

    21.53

  • 52 Week High

    90.85

  • 52 Week Low

    66.00

  • Price BSE

    72.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    21.53

  • P/C Ratio

    24.50

  • P/E Ratio

    27.70

  • Price Vs.BV

    2.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 14.66 15.00 15.19 12.07 14.09 13.95
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 14.66 15.00 15.19 12.07 14.09 13.95
Other Income 0.47 0.34 0.28 0.20 0.11 0.31
Stock Adjustments 0.26 -0.24 0.15 0.13 0.03 -0.09
Total Income 15.39 15.10 15.62 12.40 14.23 14.17
EXPENDITURE :            
Raw Materials 10.57 10.67 11.44 8.69 10.20 10.20
Power and Fuel Cost 0.00 0.00 0.16 0.17 0.23 0.24
Employee Cost 0.87 0.83 0.83 0.77 0.76 0.76
Other Manufacturing Expenses 1.00 0.44 0.33 0.33 0.40 0.43
Selling and Administration Expenses 1.71 1.82 1.67 1.48 1.44 1.30
Miscellaneous Expenses 0.00 0.00 0.00 0.00 0.00 0.00
Employee Benefit Expenses 0.87 0.83 0.83 0.77 0.76 0.76
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 14.15 13.76 14.43 11.45 13.03 12.94
Operating Profit 1.24 1.33 1.19 0.96 1.19 1.23
Interest 0.06 0.07 0.09 0.05 0.02 0.03
Gross Profit 1.18 1.26 1.10 0.91 1.17 1.20
Depreciation 0.10 0.11 0.11 0.13 0.13 0.15
Profit Before Tax 1.08 1.15 0.99 0.78 1.04 1.05
Current Tax 0.30 0.30 0.24 0.21 0.25 0.23
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 -0.01 0.00 -0.01 -0.01 -0.01
Reported Net Profit 0.78 0.87 0.75 0.58 0.80 0.83
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 0.78 0.87 0.75 0.58 0.80 0.83
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 7.63 6.76 6.02 5.44 4.63 3.80
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 8.41 7.63 6.76 6.02 5.44 4.63
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 2.60 2.90 2.50 1.93 2.69 2.77
Earnings Per Share(Adj)-Unit Curr 2.60 2.90 2.50 1.93 2.69 2.77
Book Value 38.69 36.08 33.18 30.68 28.75 26.05
Book Value(Adj)-Unit Curr 38.69 36.08 33.18 30.68 28.75 26.05

Shareholding Pattern

  • Promoter Group

    50.04%

  • Public Share Holding

    49.96%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 427,300 14.29 427,300 2
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,068,964 35.75 1,068,964 10
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 1,496,264 50.04 1,496,264 12
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 13,475 0.45 10,375 17
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 3,800 0.13 3,800 12
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 17,449 0.58 17,449 34
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 383,044 12.81 383,044 9
Individuals holding nominal share capital up to Rs. 1 lakh 1,062,264 35.52 644,724 5,017
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 100 0.00 100 1
Others 13,904 0.47 13,904 3
Sub Total 1,494,036 49.96 1,073,396 5,093
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 2,990,300 100.00 2,569,660 5,105

Company Background

Ishita Drugs & Industries LtdPharmaceuticals - Indian - Bulk Drugs

  • Ishita Drugs & Industries Ltd
  • BSE Code : 3314.0
  • ISIN : INE806D01016

  • Incorporation Year

    1992

  • Registered Office

    Survey No 179/1 Taluka Sanand
    Village Vasna-Iyava, Ahmedabad,
    Gujarat-382170

  • Telephone

  • FAX

  • Chairman

  • Managing Director

    Jagdish Agrawal

  • Company Secretary

    Srushti Pandya

  • Auditor

    jaymin Shah & Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Big Share Services Pvt Ltd
    E-2/3 Saki Vihar Rd ,
    Ansa Indl Estate ,Saki Naka Andheri-E
    Mumbai - Mumbai - 400 072

Ishita Drugs & Industries Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Ishita Drugs 72.00 15.13 14.66 30.51 8.66
Abbott India 25,805.30 7,217.19 6,929.05 33.96 43.78
Astrazeneca Phar 6,340.60 2,304.07 2,275.58 93.45 27.86
Glaxosmi. Pharma 2,573.30 3,932.76 3,790.20 41.11 58.17
Novartis India 1,719.85 393.10 354.33 43.43 15.94
Cipla 1,392.20 20,102.60 18,979.95 42.43 13.88
Bliss GVS Pharma 637.90 773.53 729.81 41.58 12.51
Amrutanjan Healt 499.35 520.13 502.55 26.75 24.16
Fermenta Biotec. 427.55 474.15 450.25 19.96 18.77
Guj. Themis Bio. 377.25 168.25 165.82 100.87 18.05
Ambalal Sarabhai 34.90 19.52 3.94 64.63 6.77